Les projets que nous finançons (uniquement en anglais)

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

Ironman Registry

Movember Funding to Date

Global Funding AUD equivalent 18,905,25

What we seek to achieve

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Country
Spain
Co-funded
Fero Foundation EU 300,000, Industry co funding
Implemented by
Movember, The Prostate Cancer Clinical Trials Consortium
Project start date
January 2017
Project Status
In Progress

About the project

A network of global Local Data Centres and their Participating Sites provide de-identified patient clinical data (including blood samples and patient reported outcome measures to the Global Data Coordination Centre. Clinical data, Blood samples (DNA, serum, circulating tumor DNA) and patient reported outcome measures (PROMS) are collected at baseline and across the first 3 years of the project.

Physician questionnaires will also be completed to enable a better understanding of factors that influence clinical decision making. This data (de identified) will be systematically collected in each country, and provided to the global data co ordination centre for analysis and reporting to all participating sites. The resources created through the project will also enable additional research to be undertaken.

We also plan to support clinical quality and survivorship sub studies leveraging the Ironman database to improve outcomes for men.

​(Local investment EUR 1,102,584)

>
Page 1 of 33